<SEC-DOCUMENT>0001213900-23-099435.txt : 20231229
<SEC-HEADER>0001213900-23-099435.hdr.sgml : 20231229
<ACCEPTANCE-DATETIME>20231229080202
ACCESSION NUMBER:		0001213900-23-099435
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20231229
FILED AS OF DATE:		20231229
DATE AS OF CHANGE:		20231229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERITY THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49843
		FILM NUMBER:		231524327

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000
		BUSINESS PHONE:		61 3 9349 4906

	MAIL ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRANA BIOTECHNOLOGY LTD
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea190893-6k_alterity.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-163</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of December 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alterity
Therapeutics Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm">333-251073</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm">333-248980</A>
and <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm">333-228671</A>) and our
Registration Statements on Form F-3 (Files No. <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm">333-274816</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm">333-251647</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm">333-231417</A>
and <A HREF="http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm">333-250076</A>)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALTERITY
THERAPEUTICS LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a
development stage enterprise)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are submitted:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="width: 8%; font-size: 10pt"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 91%; font-size: 10pt"><A HREF="ea190893ex99-1_alterity.htm">Results of Extraordinary General Meeting</A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SIGNATURE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alterity Therapeutics Limited</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Geoffrey P. Kempler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 37%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geoffrey P. Kempler</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: capitalize; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
</FONT>December 29, 2023</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea190893ex99-1_alterity.htm
<DESCRIPTION>RESULTS OF EXTRAORDINARY GENERAL MEETING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Results of Extraordinary General
Meeting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><B>MELBOURNE, AUSTRALIA AND SAN
FRANCISCO, USA - 29 December 2023 </B>Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (&ldquo;Alterity&rdquo; or &ldquo;the Company&rdquo;)
advises that all resolutions considered at the Extraordinary General Meeting held today were carried by poll.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">In accordance with ASX Listing rule 3.13.2
and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Phillip Hains <BR>
Company Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Alterity Therapeutics Limited
ACN 080 699 065</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Level 3, 62 Lygon Street Carlton
Victoria 3053 Australia <BR>
www.alteritytherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin: 12pt 0pt 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="margin: 6pt 0pt 12pt; break-before: page"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Alterity Therapeutics Limited<BR>
                         </B> <B>Extraordinary General Meeting <BR>
                         Friday, 29 December 2023</B><BR>
                         <B>Results of Meeting</B></P></TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="vertical-align: middle; text-align: right; width: 33%"><IMG SRC="ex99-1_002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-left: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The following information is provided in accordance with
section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 6.55pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D8D8D8">
    <TD COLSPAN="2" STYLE="padding: 2.5pt; border: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Resolution details</B></FONT></TD>
    <TD COLSPAN="4" STYLE="padding: 2.5pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt"><B>Instructions given to validly appointed proxies</B> <B>(as at proxy close)</B></TD>
    <TD COLSPAN="3" STYLE="padding: 2.5pt; text-align: center; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 2.5pt"><B>Number of votes cast on the poll</B> <B>(where applicable)</B></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; text-align: center; border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-indent: 2.5pt"><B>Resolution</B> <B>Result</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; vertical-align: middle; width: 19%; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Resolution</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; text-align: center; border-bottom: Black 1pt solid; width: 9%; text-indent: 2.5pt"><B>Resolution</B> <B>Type</B></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; text-align: center; border-bottom: Black 1pt solid; width: 9%; text-indent: 2.5pt"><B>Proxy's</B> <B>Discretion</B></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Abstain</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; border-bottom: Black 1pt solid; width: 9%; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Abstain*</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2.5pt; vertical-align: middle; text-align: center; border-bottom: Black 1pt solid; width: 9%; text-indent: 2.5pt"><B>Carried /</B> <B>Not Carried</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">1 Ratification of prior issue of Shares</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">150,828,432 81.93%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">29,952,074 16.27%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,312,470 1.80%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">2,351,400</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">154,140,902 83.73%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">29,952,074 16.27%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">6,351,400</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">2 Approval for issue of Shares</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">139,071,294 76.58%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">39,235,586 21.60%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,312,470 1.82%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">4,845,426</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">142,383,764 78.40%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">39,235,586 21.60%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">8,845,426</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">3 Approval for issue of Options</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">138,253,594 76.54%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">39,033,686 21.61%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,332,470 1.85%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">5,644,626</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">141,586,064 78.39%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">39,033,686 21.61%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">9,644,626</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">4 Approval for issue of Securities - SPP</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">135,532,712 73.88%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">44,583,474 24.30%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,332,470 1.82%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">4,850,126</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">130,648,470 74.56%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">44,583,474 25.44%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">17,066,838</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">5A Approval of issue of Securities - Placement - Peter Marks</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">136,391,908 73.89%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,181,628 24.47%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,024,662 1.64%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">3,543,984</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">139,416,570 75.52%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,181,628 24.48%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">7,543,984</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">5B Approval of issue of Securities - Placement - Brian Meltzer</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">135,291,600 73.16%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,622,628 24.67%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">4,016,970 2.17%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">3,327,984</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">139,308,570 75.33%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,622,628 24.67%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">7,327,984</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2.5pt 2.5pt 2.5pt 0.125in; text-indent: -0.125in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">5C Approval of issue of Securities - Placement - Lawrence Gozlan</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Ordinary</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">136,345,000 73.71%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,610,628 24.66%</TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: middle; padding: 2.5pt; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">3,016,970 1.63%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">3,326,184</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">139,361,970 75.34%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; text-indent: 2.5pt">45,610,628 24.66%</TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">7,326,184</FONT></TD>
    <TD STYLE="vertical-align: middle; padding: 2.5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; text-indent: 2.5pt"><FONT STYLE="font-size: 10pt">Carried</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">* Votes cast by a person who abstains on an item are not
counted in calculating the required majority on a poll.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != 74# 2(  A$! Q$!_\0
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MWA,2K)J.GIAQEI8AW]6'O[5RWAWPY/KUWCF.UC/[V3^@]Z]@K \(HJ:1*%4
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M4LKGG"AP2:YL+@_:QE*=UV\QRG;8^VZ*X^#XJ>";FXC@AUZ%Y9'"(HCDY).
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MF"(XDDC95.<<XKR6YBD@F>*52LBG# ]0:]CK"\1>'H]7A,L0"7:CANSCT/\
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M _K7IUO;PVEM%;6\2Q0Q*$CC08"J!@ "N/$SH.*C1145+J?-'Q__ .2AP_\
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#(__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  E ,<# 2(  A$! Q$!_\0
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MDZD6I6?8Z*M>#C4Y7_+\[;G*_!C3;*\U[6I+FVBF,,:K&)%#!0S-G@_04?"
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
